International Multicenter Study of the Navitor/Navitor Vision Transcatheter Aortic Valve Platform

NCT07359898 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2026-01-22

No results posted yet for this study

Summary

INTENSIVE is a prospective, single-arm, multi-center, international, investigator-initiated study of the Navitor/Navitor Vision Transcatheter Aortic Valve (Navitor/Navitor Vision Valve) in patients with symptomatic, severe native aortic stenosis to monitor the outcomes of this valve in a real-world clinical setting.

Conditions

  • Severe Native Aortic Stenosis

Sponsors & Collaborators

  • Meditrial SrL

    collaborator INDUSTRY
  • Abbott

    collaborator INDUSTRY
  • IRCCS Policlinico S. Donato

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-10-11
Primary Completion
2027-10-31
Completion
2031-10-31

Countries

  • Italy

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07359898 on ClinicalTrials.gov